Skip to main content

Table 5 Network meta-analysis results of optimal transplantation route

From: The optimal transplantation strategy of umbilical cord mesenchymal stem cells in spinal cord injury: a systematic review and network meta-analysis based on animal studies

Group

The third week (SMD)

The fifth week (SMD)

Acute phase + high dose transplantation

 − 0.84 (− 5.29, 3.44)

 − 0.49 (− 5.75, 5.01)

Acute phase + low dose transplantation

0.06 (− 1.26, 1.41)

 − 1.06 (− 3.56, 1.39)

Subacute phase + high dose transplantation

2.14 (− 0.90, 5.40)

1.53 (− 1.73, 4.80)